Trial Profile
RANDOMISED PILOT STUDY TO ASSESS THE CLINICAL EFFICACY OF DAYLIGHT PHOTODYNAMIC THERAPY WITH METHYL AMINOLEVULINATE CREAM (METVIX), (MAL-PDT), IN THE PREVENTION OF ACTINIC KERATOSIS AND NON MELANOMA SKIN CANCER IN TRANSPLANT PATIENTS
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Feb 2023
Price :
$35
*
At a glance
- Drugs Methyl aminolevulinate (Primary) ; Methyl aminolevulinate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 30 Dec 2018 Status changed from recruiting to completed.
- 25 Nov 2015 New trial record